Suppr超能文献

针刺联合中药及药物疗法治疗脑梗死(痰瘀阻络证)及颈动脉粥样硬化斑块的初步随机对照研究

Acupuncture Combined with Traditional Chinese Medicine and Drug Therapy for the Treatment of Cerebral Infarction (Phlegm-Blood Stasis Syndrome) and Carotid Atherosclerotic Plaque: A Preliminary Randomized Controlled Study.

作者信息

Wang Wentong, Liu Zhuli, Wu Yongxiong

机构信息

Department of Encephalopathy, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong 518100, China.

Inpatient Dispensary, Wuyi Traditional Chinese Medicine Hospital, No. 30 East Huayuan Road, Jiangmen, Guangdong 529000, China.

出版信息

Appl Bionics Biomech. 2022 Jun 15;2022:5143408. doi: 10.1155/2022/5143408. eCollection 2022.

Abstract

Carotid atherosclerotic plaque (CAP) is one of the leading causes of cerebral infarction. Western medicine usually uses lipid-lowering drugs to stabilize plaques. Currently, studies reporting on drugs that can reduce plaques are lacking. Here, we performed a randomized controlled study to investigate the effectiveness of acupuncture combined with drug therapy (TCM and Western) to treat cerebral infarction (phlegm-blood stasis syndrome) and CAP. The control group was treated with atorvastatin calcium tablets (20 mg/d, po for 15 days). The treatment group received atorvastatin calcium tablets 20 mg, traditional Chinese medicine (TCM) decoctions (two matured substance decoction plus peach kernel and Carthamus four substance decoction plus Chinese hawthorn fruit 20 g, gold theragran 20 g, and red yeast rice 3 g), and acupuncture therapy, once daily for 15 days as one treatment course. The patients' neurological deficit score, ultrasonic testing of the carotid artery, and lipoprotein-associated phospholipase A2 (Lp-PLA2) were evaluated. Our findings showed no significant difference in the evaluated indices between the two groups before treatment ( > 0.05). However, compared with the control group after 15 days of treatment and within each group before and after treatment, the differences were significant ( < 0.05). In conclusion, acupuncture combined with drug therapy demonstrated promising effectiveness in treating cerebral infarction (phlegm-blood stasis syndrome) and CAP.

摘要

颈动脉粥样硬化斑块(CAP)是脑梗死的主要病因之一。西医通常使用降脂药物来稳定斑块。目前,关于能够缩小斑块的药物的研究尚缺。在此,我们进行了一项随机对照研究,以调查针刺联合药物治疗(中药和西药)对脑梗死(痰瘀阻络证)和CAP的疗效。对照组服用阿托伐他汀钙片(20毫克/天,口服,共15天)。治疗组服用20毫克阿托伐他汀钙片、中药汤剂(二陈汤加桃仁四物汤加焦山楂20克、金施尔康20克、红曲3克),并接受针刺治疗,每天1次,15天为一个疗程。评估患者的神经功能缺损评分、颈动脉超声检查以及脂蛋白相关磷脂酶A2(Lp-PLA2)。我们的研究结果显示,治疗前两组的评估指标无显著差异(>0.05)。然而,与治疗15天后的对照组以及每组治疗前后相比,差异具有统计学意义(<0.05)。总之,针刺联合药物治疗在治疗脑梗死(痰瘀阻络证)和CAP方面显示出有前景的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c1/9217605/b0916e11c868/ABB2022-5143408.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验